DoW Melanoma Research Program Melanoma Academy Scholar Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Publié 21 mai 2026 · 6 jours restants
En clair
Résumé pas encore disponible en français ; affiché en anglais.
The US Defense Health Agency funds early-career melanoma researchers within seven years of their first faculty appointment to join a virtual Melanoma Academy for research and career development, with mentorship from established investigators. Applications are unrestricted by organization type but limited to US entities, with a deadline of 14 October 2026.
Un résumé généré du texte du bailleur ; la formulation originale figure ci-dessous.
Résumé
Texte original du bailleur (anglais)
Summary: Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment.
Distinctive Features:
This award mechanism focuses on both the Scholar’s research and career potential in the melanoma field.
Scholars must designate a Career Guide. The Career Guide must have a track record of successful mentorship coupled with a strong record of funding and publications in melanoma.
Preliminary data are not required.
Extrait de la page du bailleur. Le texte intégral, les annexes et les formulaires se trouvent dans l'appel original.
Qui peut candidater
- ONG / société civile
- Établissement universitaire ou de recherche
- Entreprise privée
- Organisme public
- Entreprise sociale ou coopérative
- Particulier
- Autre type de candidat
Éligibilité et conditions
Afficher le texte d'éligibilité de la source · Texte original du bailleur (anglais)
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"